Matthew Maenner is surveillance team lead for the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention.
Matthew Maenner
Surveillance team lead
National Center on Birth Defects and Developmental Disabilities
From this contributor
Q&A with Matthew Maenner: Estimating autism prevalence quickly
A new method to track autism prevalence in 11 U.S. states is twice as fast as the old approach — and yields similar results.
Q&A with Matthew Maenner: Estimating autism prevalence quickly
Explore more from The Transmitter
The silent majority: How astrocytes shape the brain across scales
Melissa Cooper talks to Mac Shine about her new work that reveals how these glial cells—long dismissed as the brain’s housekeepers—wire together in precise, long-range networks that remodel in response to experience.
The silent majority: How astrocytes shape the brain across scales
Melissa Cooper talks to Mac Shine about her new work that reveals how these glial cells—long dismissed as the brain’s housekeepers—wire together in precise, long-range networks that remodel in response to experience.
Untangling genetic effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 11 May.
Untangling genetic effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 11 May.
The next unit of science: Is the scientific paper due to be replaced?
Artificial intelligence is pushing scientific publishing to the brink. For a field as sprawling as neuroscience, the crisis may also be an opportunity to finally connect findings across subfields.
The next unit of science: Is the scientific paper due to be replaced?
Artificial intelligence is pushing scientific publishing to the brink. For a field as sprawling as neuroscience, the crisis may also be an opportunity to finally connect findings across subfields.